SERMORELIN KITS

Description

Sermorelin is a synthetic peptide modeled after the first 29 amino acids of naturally occurring human growth hormone-releasing hormone, also known as GHRH or growth hormone-releasing factor. It has been investigated for its interaction with GHRH receptors and its effects on pituitary signaling, endogenous growth hormone release, and related endocrine pathways.

Research Applications

• GHRH Receptor Interaction Studies
• Pituitary Signaling Research
• Endogenous Growth Hormone Secretion Studies
• Growth Hormone and IGF-1 Pathway Research
• Endocrine Feedback-Mechanism Investigation
• Peptide-Receptor Activity Analysis

Scientific Background

Sermorelin is an amidated 29-amino-acid peptide corresponding to the biologically active amino-terminal segment of the naturally occurring 44-amino-acid human GHRH peptide. It is commonly identified as GRF(1–29)-NH₂.

Researchers study Sermorelin for its ability to activate GHRH receptors located on pituitary somatotroph cells. This receptor interaction is associated with signaling pathways involved in the synthesis and pulsatile release of endogenous growth hormone. Its molecular characteristics, receptor-binding activity, and endocrine effects continue to be examined in controlled research environments.

Specifications

Compound: Sermorelin
Alternative Name: GRF(1–29)-NH₂
Category: Synthetic Research Peptide
Classification: GHRH Analog
Peptide Length: 29 Amino Acids
Form: Lyophilized Powder
Purity: See Current COA
Use: Research and Analytical Applications

Research Use Only

This product is supplied exclusively for laboratory research and analytical purposes. It is not intended for human consumption, self-administration, medical use, diagnostic use, veterinary use, or therapeutic application. It should be handled only by qualified professionals in an appropriate laboratory or research environment.